{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:25:52Z","timestamp":1788474352306,"version":"build-2803163510"},"reference-count":49,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background: Staphylococcus aureus bloodstream infection remains a major clinical challenge because of its association with invasive disease, antimicrobial resistance, biofilm formation, and substantial mortality. Local susceptibility surveillance is essential for guiding empirical therapy and antimicrobial stewardship. This study evaluated the epidemiology, resistance patterns, turnaround time, and clinical correlates of S. aureus bacteremia in a Romanian tertiary-care hospital. Methods: We conducted a retrospective, single-center observational study including all consecutive adults with positive blood cultures for S. aureus admitted to Sibiu County Clinical Emergency Hospital between 1 January 2024 and 31 December 2025. Demographic, clinical, microbiological, antimicrobial susceptibility, and outcome data were extracted from electronic medical records. MRSA was defined phenotypically, while MDR and XDR phenotypes were classified according to standard resistance definitions. Between-year comparisons and regression analyses were performed to explore factors associated with mortality, MRSA, and MDR status. Results: During the study period, 11,578 blood culture sets were processed, of which 2472 (21.3%) were positive; S. aureus accounted for 314 isolates (12.7% of positive cultures). After one isolate per patient was retained, the final analysis included 142 patients with S. aureus bacteremia. Median age was 70 years, 55.6% were male, and 67.6% lived in urban areas. Overall mortality was 33.1% (47\/142). MRSA was identified in 39.4% of cases and MDR in 49.3%, while no XDR isolates were detected. The most frequent resistances were observed for penicillin (75.9%), erythromycin (66.2%), clindamycin (46.5%), tetracycline (45.1%), and oxacillin (38.0%). Full susceptibility was preserved for vancomycin, linezolid, ceftaroline, daptomycin, and mupirocin. Turnaround time significantly improved in 2025 compared with 2024 (median 71.4 h vs. 66.3 h; p = 0.004). In adjusted analysis, acute or chronic kidney disease was independently associated with mortality, whereas MRSA and MDR status were not independent predictors of death. Conclusions: In this single-center cohort, S. aureus bacteremia was associated with high mortality and a substantial burden of MRSA and MDR phenotypes, although preserved activity of key anti-staphylococcal agents was observed. These findings support the need for continuous local resistance surveillance, rapid microbiological diagnosis, and stewardship-guided treatment strategies.<\/jats:p>","DOI":"10.3390\/antibiotics15070695","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:12:38Z","timestamp":1784257958000},"page":"695","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Susceptibility of Staphylococcus aureus Strains Isolated from Blood Cultures Between 2024 and 2025: A Single-Center Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7391-3394","authenticated-orcid":false,"given":"Victoria","family":"Birlutiu","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Lucian Blaga University of Sibiu, Str. Lucian Blaga, Nr. 2A, 550169 Sibiu, Romania"},{"name":"County Clinical Emergency Hospital, Bvd Corneliu Coposu, Nr. 2\u20134, 550245 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olteanu","family":"Ciprian Ion","sequence":"additional","affiliation":[{"name":"County Clinical Emergency Hospital, Bvd Corneliu Coposu, Nr. 2\u20134, 550245 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7400-2904","authenticated-orcid":false,"given":"Rares-Mircea","family":"Birlutiu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"\u201cFoisor\u201d Clinical Hospital of Orthopaedics, Traumatology and Osteoarticular TB, 021382 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kimmig, A., Hagel, S., Weis, S., Bahrs, C., L\u00f6ffler, B., and Pletz, M.W. (2021). Management of Staphylococcus aureus Bloodstream Infections. Front. Med., 7.","DOI":"10.3389\/fmed.2020.616524"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1469-0691.2012.03903.x","article-title":"The Changing Epidemiology of Staphylococcus aureus Bloodstream Infection: A Multinational Population-Based Surveillance Study","volume":"19","author":"Laupland","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jinf.2018.08.015","article-title":"Survival Following Staphylococcus aureus Bloodstream Infection: A Prospective Multinational Cohort Study Assessing the Impact of Place of Care","volume":"77","author":"Nambiar","year":"2018","journal-title":"J. Infect."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0140-6736(17)32456-X","article-title":"Adjunctive Rifampicin for Staphylococcus aureus Bacteraemia (ARREST): A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial","volume":"391","author":"Thwaites","year":"2018","journal-title":"Lancet"},{"key":"ref_5","unstructured":"World Health Organization (2024). WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance, World Health Organization."},{"key":"ref_6","unstructured":"World Health Organization (2022). 2022 Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2022, World Health Organization."},{"key":"ref_7","unstructured":"ECDC (2026, May 09). Antimicrobial Resistance in the EU\/EEA (EARS-Net) Annual Epidemiological Report for 2024, Available online: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/antimicrobial-resistance-eu-annual-epidemiological-report-2024.pdf#:~:text=In%202024%2C%20the%20estimated%20total%20EU%20incidence,detected%20between%202019%20(baseline%20year)%20and%202024."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Birlutiu, V., and Birlutiu, R.-M. (2025). An Overview of the Epidemiology of Multidrug Resistance and Bacterial Resistance Mechanisms: What Solutions Are Available? A Comprehensive Review. Microorganisms, 13.","DOI":"10.3390\/microorganisms13092194"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tim.2008.11.005","article-title":"Staphylococcus aureus: New Evidence for Intracellular Persistence","volume":"17","author":"Garzoni","year":"2009","journal-title":"Trends Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmi.2016.06.020","article-title":"Post-Invasion Events after Infection with Staphylococcus aureus Are Strongly Dependent on Both the Host Cell Type and the Infecting S. aureus Strain","volume":"22","author":"Strobel","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.diagmicrobio.2006.10.021","article-title":"Community- and Health Care-Associated Methicillin-Resistant Staphylococcus aureus: A Comparison of Molecular Epidemiology and Antimicrobial Activities of Various Agents","volume":"58","author":"Tsuji","year":"2007","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/CMR.00081-09","article-title":"Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic","volume":"23","author":"David","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-biochem-060614-034516","article-title":"Mechanisms of Methicillin Resistance in Staphylococcus aureus","volume":"84","author":"Peacock","year":"2015","journal-title":"Annu. Rev. Biochem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1042\/BST20253064","article-title":"Mechanisms of Fusidic Acid Resistance","volume":"53","author":"Selmer","year":"2025","journal-title":"Biochem. Soc. Trans."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/23744235.2017.1392039","article-title":"Staphylococcus aureus Bacteraemia and Endocarditis\u2014Epidemiology and Outcome: A Review","volume":"50","author":"Asgeirsson","year":"2018","journal-title":"Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/cid\/cit499","article-title":"Impact of an Evidence-Based Bundle Intervention in the Quality-of-Care Management and Outcome of Staphylococcus aureus Bacteremia","volume":"57","author":"Farinas","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0195-6701(98)90022-6","article-title":"Positive Intravenous Line Tip Cultures as Predictors of Bacteraemia","volume":"40","author":"Peacock","year":"1998","journal-title":"J. Hosp. Infect."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1086\/320001","article-title":"Guidelines for the Management of Intravascular Catheter-Related Infections","volume":"32","author":"Mermel","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1086\/524077","article-title":"Bacteremic Complications of Intravascular Catheters Colonized with Staphylococcus aureus","volume":"46","author":"Ekkelenkamp","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00277-020-04286-x","article-title":"Central Venous Catheter\u2013Related Infections in Hematology and Oncology: 2020 Updated Guidelines on Diagnosis, Management, and Prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)","volume":"100","author":"Schalk","year":"2021","journal-title":"Ann. Hematol."},{"key":"ref_21","unstructured":"European Committee on Antimicrobial Susceptibility Testing (2025). Clinical Breakpoints and Interpretation of Clinical MICs, Version 15, European Committee on Antimicrobial Susceptibility Testing."},{"key":"ref_22","unstructured":"European Committee on Antimicrobial Susceptibility Testing (2024). Clinical Breakpoints and Interpretation of Clinical MICs, Version 14, European Committee on Antimicrobial Susceptibility Testing."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Bacteria: An International Expert Proposal for Interim Standard Definitions for Acquired Resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"ofac653","DOI":"10.1093\/ofid\/ofac653","article-title":"All-Cause and Infection-Related Mortality in Staphylococcus aureus Bacteremia, a Multicenter Prospective Cohort Study","volume":"9","author":"Prins","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Le Moing, V., Alla, F., Doco-Lecompte, T., Delahaye, F., Piroth, L., Chirouze, C., Tattevin, P., Lavigne, J.-P., Erpelding, M.-L., and Hoen, B. (2015). Staphylococcus aureus Bloodstream Infection and Endocarditis\u2014A Prospective Cohort Study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0127385"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10096-018-3239-1","article-title":"Increased Overall Survival after Introduction of Structured Bedside Consultation in Staphylococcus aureus Bacteraemia","volume":"37","author":"Ariaans","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S1473-3099(20)30447-3","article-title":"Defining Persistent Staphylococcus aureus Bacteraemia: Secondary Analysis of a Prospective Cohort Study","volume":"20","author":"Kuehl","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Birlutiu, R.-M., and Birlutiu, V. (2025). Oritavancin a Therapeutic Option for Periprosthetic Joint Infections in Selected Cases: A Comprehensive Review. Pharmaceuticals, 18.","DOI":"10.3390\/ph18081217"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Dragosloveanu, S., Birlutiu, R.-M., Neamtu, B., and Birlutiu, V. (2025). Microbiological Profiles, Antibiotic Susceptibility Patterns and the Role of Multidrug-Resistant Organisms in Patients Diagnosed with Periprosthetic Joint Infection over 8 Years: Results from a Single-Center Observational Cohort Study from Romania. Microorganisms, 13.","DOI":"10.3390\/microorganisms13051168"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amjmed.2022.09.017","article-title":"The Golden Grapes of Wrath\u2014Staphylococcus aureus Bacteremia: A Clinical Review","volume":"136","author":"Lam","year":"2023","journal-title":"Am. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","article-title":"2015 ESC Guidelines for the Management of Infective Endocarditis","volume":"36","author":"Habib","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cid\/civ235","article-title":"Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT): Scoring System to Guide Use of Echocardiography in the Management of Staphylococcus aureus Bacteremia","volume":"61","author":"Palraj","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/MD.0b013e31824d7ed2","article-title":"Metastatic Infectious Disease and Clinical Outcome in Staphylococcus aureus and Streptococcus Species Bacteremia","volume":"91","author":"Vos","year":"2012","journal-title":"Medicine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmi.2022.03.015","article-title":"Staphylococcus aureus Bacteraemia Mortality: A Systematic Review and Meta-Analysis","volume":"28","author":"Bai","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e1921048","DOI":"10.1001\/jamanetworkopen.2019.21048","article-title":"Association of Infectious Diseases Consultation with Long-Term Postdischarge Outcomes Among Patients with Staphylococcus aureus Bacteremia","volume":"3","author":"Goto","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1053\/j.ajkd.2021.06.018","article-title":"Staphylococcus aureus Bacteremia Among Patients Receiving Maintenance Hemodialysis: Trends in Clinical Characteristics and Outcomes","volume":"79","author":"Sinclair","year":"2022","journal-title":"Am. J. Kidney Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2215\/CJN.01301005","article-title":"Relationship between Clinical Outcomes and Vascular Access Type among Hemodialysis Patients with Staphylococcus aureus Bacteremia","volume":"1","author":"Inrig","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"T\u0103l\u0103pan, D., Sandu, A.-M., and Rafila, A. (2023). Antimicrobial Resistance of Staphylococcus aureus Isolated between 2017 and 2022 from Infections at a Tertiary Care Hospital in Romania. Antibiotics, 12.","DOI":"10.3390\/antibiotics12060974"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Foti, C., Piperno, A., Scala, A., and Giuffr\u00e8, O. (2021). Oxazolidinone Antibiotics: Chemical, Biological and Analytical Aspects. Molecules, 26.","DOI":"10.3390\/molecules26144280"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s40265-020-01443-4","article-title":"Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia","volume":"81","author":"Zhanel","year":"2021","journal-title":"Drugs"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/S1473-3099(18)30711-4","article-title":"Potential of Marine Natural Products against Drug-Resistant Bacterial Infections","volume":"19","author":"Liu","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Dash, R., and Bhattacharjya, S. (2021). Thanatin: An Emerging Host Defense Antimicrobial Peptide with Multiple Modes of Action. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041522"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Piller, P., Wolinski, H., Cordfunke, R.A., Drijfhout, J.W., Keller, S., Lohner, K., and Malanovic, N. (2022). Membrane Activity of LL-37 Derived Antimicrobial Peptides against Enterococcus hirae: Superiority of SAAP-148 over OP-145. Biomolecules, 12.","DOI":"10.3390\/biom12040523"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Gajd\u00e1cs, M. (2019). The Continuing Threat of Methicillin-Resistant Staphylococcus aureus. Antibiotics, 8.","DOI":"10.3390\/antibiotics8020052"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Bibens, L., Becker, J.-P., Dassonville-Klimpt, A., and Sonnet, P. (2023). A Review of Fatty Acid Biosynthesis Enzyme Inhibitors as Promising Antimicrobial Drugs. Pharmaceuticals, 16.","DOI":"10.3390\/ph16030425"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"103169","DOI":"10.1016\/j.bioorg.2019.103169","article-title":"FtsZ Inhibitors as a New Genera of Antibacterial Agents","volume":"91","author":"Tripathy","year":"2019","journal-title":"Bioorg. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1039\/D3MD00226H","article-title":"Restoring Susceptibility to Aminoglycosides: Identifying Small Molecule Inhibitors of Enzymatic Inactivation","volume":"14","author":"Sklenicka","year":"2023","journal-title":"RSC Med. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"101147","DOI":"10.1016\/j.drup.2024.101147","article-title":"Mechanism of Staphylococcal Resistance to Clinically Relevant Antibiotics","volume":"77","author":"Ruml","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mib.2020.02.005","article-title":"Staphylococcus aureus Bloodstream Infections: Pathogenesis and Regulatory Mechanisms","volume":"53","author":"Kwiecinski","year":"2020","journal-title":"Curr. Opin. Microbiol."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/7\/695\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:52:54Z","timestamp":1784260374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/7\/695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["antibiotics15070695"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15070695","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]}}}